综合性网络药理学和实验研究青达颗粒在高血压引起的内皮功能障碍中
Yanyan Yang1,2,3,4,5, Qiurong Xie1,2,3,4,5, Jingyi Zeng1,2
1Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine.
Experimental animals
|October 29, 2025
概括
青达颗粒 (QDG) 有效降低血压,改善高血压中的内皮功能. 它通过NF-κB通路抑制炎症和细胞粘附,为血管并发症提供了有前途的治疗方法.
科学领域:
- 心血管药理学心血管药理学
- 综合医学是一个整体的医学.
- 分子生物学分子生物学
背景情况:
- 内皮功能障碍 (ED) 是高血压病变和血管并发症的核心原因.
- 青达颗粒 (QDG) 显示出抗高血压作用和治疗血管功能障碍的潜力.
研究的目的:
- 调查QDG在改善高血压诱导的内皮损伤方面的疗效.
- 阐明QDG治疗作用的潜在分子机制.
主要方法:
- 使用一种N-Nitro-L-arginine甲基 (L-NAME) 诱导的高血压小鼠模型.
- 通过组织学评估内皮功能,氧化 (NO) 水平和血管反应.
- 采用网络药理学和免疫组织化学来分析关键的分子通路和蛋白质表达 (NF-κB,ICAM-1,TNF-α).
主要成果:
- 在高血压小鼠中,QDG治疗显著降低了血压,并增加了NO水平.
- QDG增强了内皮氧化合成酶 (eNOS) 表达,恢复了内皮功能.
- QDG抑制了p-NF-κB p65,TNF-α和ICAM-1的表达,表明炎症和细胞粘附减少.
结论:
- QDG通过通过NF-κB信号通路抑制炎症和内皮粘附来缓解高血压诱导的内皮功能障碍.
- 在治疗高血压和相关的血管并发症方面,QDG具有显著的治疗潜力.
更多相关视频
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
915
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
915
Antihypertensive Drugs: Vasodilators
2.0K
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
2.0K
Hypertension II: Pathophysiology
771
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
771
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.3K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.3K
Neural Regulation of Blood Pressure
6.8K
The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
6.8K
Antihypertensive Drugs: Direct Renin Inhibitors
1.3K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.3K


